vs
Liberty Energy Inc.（LBRT）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Liberty Energy Inc.的季度营收约是Royalty Pharma plc的1.6倍（$1.0B vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs 2.2%，领先32.2%），Royalty Pharma plc同比增速更快（4.8% vs 4.5%），过去两年Royalty Pharma plc的营收复合增速更高（4.6% vs -6.2%）
Liberty Energy Inc.是北美领先的能源服务供应商，专注为油气运营企业提供水力压裂及完井解决方案，服务覆盖美国主要页岩产区，供应低排放作业设备及定制化支持，帮助提升油气井生产效率。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
LBRT vs RPRX — 直观对比
营收规模更大
LBRT
是对方的1.6倍
$622.0M
营收增速更快
RPRX
高出0.3%
4.5%
净利率更高
RPRX
高出32.2%
2.2%
两年增速更快
RPRX
近两年复合增速
-6.2%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.0B | $622.0M |
| 净利润 | $22.6M | $214.2M |
| 毛利率 | — | — |
| 营业利润率 | 2.2% | 62.4% |
| 净利率 | 2.2% | 34.4% |
| 营收同比 | 4.5% | 4.8% |
| 净利润同比 | — | 2.9% |
| 每股收益（稀释后） | $0.14 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LBRTRPRX
| Q1 26 | $1.0B | — | ||
| Q4 25 | $1.0B | $622.0M | ||
| Q3 25 | $947.4M | $609.3M | ||
| Q2 25 | $1.0B | $578.7M | ||
| Q1 25 | $977.5M | $568.2M | ||
| Q4 24 | $943.6M | $593.6M | ||
| Q3 24 | $1.1B | $564.7M | ||
| Q2 24 | $1.2B | $537.3M |
净利润LBRTRPRX
| Q1 26 | $22.6M | — | ||
| Q4 25 | $13.7M | $214.2M | ||
| Q3 25 | $43.1M | $288.2M | ||
| Q2 25 | $71.0M | $30.2M | ||
| Q1 25 | $20.1M | $238.3M | ||
| Q4 24 | $51.9M | $208.2M | ||
| Q3 24 | $73.8M | $544.0M | ||
| Q2 24 | $108.4M | $102.0M |
毛利率LBRTRPRX
| Q1 26 | — | — | ||
| Q4 25 | 20.6% | — | ||
| Q3 25 | 18.7% | — | ||
| Q2 25 | 22.1% | — | ||
| Q1 25 | 22.1% | — | ||
| Q4 24 | 21.4% | — | ||
| Q3 24 | 26.2% | — | ||
| Q2 24 | 27.9% | — |
营业利润率LBRTRPRX
| Q1 26 | 2.2% | — | ||
| Q4 25 | 1.9% | 62.4% | ||
| Q3 25 | -0.3% | 70.1% | ||
| Q2 25 | 3.6% | 36.3% | ||
| Q1 25 | 1.9% | 94.0% | ||
| Q4 24 | 2.6% | 60.9% | ||
| Q3 24 | 9.4% | — | ||
| Q2 24 | 12.2% | 50.2% |
净利率LBRTRPRX
| Q1 26 | 2.2% | — | ||
| Q4 25 | 1.3% | 34.4% | ||
| Q3 25 | 4.5% | 47.3% | ||
| Q2 25 | 6.8% | 5.2% | ||
| Q1 25 | 2.1% | 41.9% | ||
| Q4 24 | 5.5% | 35.1% | ||
| Q3 24 | 6.5% | 96.3% | ||
| Q2 24 | 9.3% | 19.0% |
每股收益（稀释后）LBRTRPRX
| Q1 26 | $0.14 | — | ||
| Q4 25 | $0.08 | $0.49 | ||
| Q3 25 | $0.26 | $0.67 | ||
| Q2 25 | $0.43 | $0.07 | ||
| Q1 25 | $0.12 | $0.55 | ||
| Q4 24 | $0.31 | $0.46 | ||
| Q3 24 | $0.44 | $1.21 | ||
| Q2 24 | $0.64 | $0.23 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $699.1M | $618.7M |
| 总债务越低越好 | $7.1M | $9.0B |
| 股东权益账面价值 | $1.9B | $9.7B |
| 总资产 | $4.4B | $19.6B |
| 负债/权益比越低杠杆越低 | 0.00× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资LBRTRPRX
| Q1 26 | $699.1M | — | ||
| Q4 25 | $27.6M | $618.7M | ||
| Q3 25 | $13.5M | $938.9M | ||
| Q2 25 | $19.6M | $631.9M | ||
| Q1 25 | $24.1M | $1.1B | ||
| Q4 24 | $20.0M | $929.0M | ||
| Q3 24 | $23.0M | $950.1M | ||
| Q2 24 | $30.0M | $1.8B |
总债务LBRTRPRX
| Q1 26 | $7.1M | — | ||
| Q4 25 | $246.6M | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | $190.5M | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B |
股东权益LBRTRPRX
| Q1 26 | $1.9B | — | ||
| Q4 25 | $2.1B | $9.7B | ||
| Q3 25 | $2.1B | $9.6B | ||
| Q2 25 | $2.0B | $9.5B | ||
| Q1 25 | $2.0B | $9.8B | ||
| Q4 24 | $2.0B | $10.3B | ||
| Q3 24 | $2.0B | $10.3B | ||
| Q2 24 | $1.9B | $9.8B |
总资产LBRTRPRX
| Q1 26 | $4.4B | — | ||
| Q4 25 | $3.6B | $19.6B | ||
| Q3 25 | $3.5B | $19.3B | ||
| Q2 25 | $3.4B | $18.3B | ||
| Q1 25 | $3.4B | $17.6B | ||
| Q4 24 | $3.3B | $18.2B | ||
| Q3 24 | $3.3B | $18.0B | ||
| Q2 24 | $3.2B | $17.7B |
负债/权益比LBRTRPRX
| Q1 26 | 0.00× | — | ||
| Q4 25 | 0.12× | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | 0.10× | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $827.1M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | 13.1% | — |
| 现金转化率经营现金流/净利润 | — | 3.86× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流LBRTRPRX
| Q1 26 | — | — | ||
| Q4 25 | $195.4M | $827.1M | ||
| Q3 25 | $51.5M | $702.6M | ||
| Q2 25 | $170.6M | $364.0M | ||
| Q1 25 | $192.1M | $596.1M | ||
| Q4 24 | $177.3M | $742.5M | ||
| Q3 24 | $244.5M | $703.6M | ||
| Q2 24 | $248.2M | $658.2M |
自由现金流LBRTRPRX
| Q1 26 | — | — | ||
| Q4 25 | $-10.0M | — | ||
| Q3 25 | $-67.2M | — | ||
| Q2 25 | $33.1M | — | ||
| Q1 25 | $58.2M | — | ||
| Q4 24 | $-26.2M | — | ||
| Q3 24 | $77.9M | — | ||
| Q2 24 | $112.2M | — |
自由现金流率LBRTRPRX
| Q1 26 | — | — | ||
| Q4 25 | -1.0% | — | ||
| Q3 25 | -7.1% | — | ||
| Q2 25 | 3.2% | — | ||
| Q1 25 | 6.0% | — | ||
| Q4 24 | -2.8% | — | ||
| Q3 24 | 6.8% | — | ||
| Q2 24 | 9.7% | — |
资本支出强度LBRTRPRX
| Q1 26 | 13.1% | — | ||
| Q4 25 | 19.8% | — | ||
| Q3 25 | 12.5% | — | ||
| Q2 25 | 13.2% | — | ||
| Q1 25 | 13.7% | — | ||
| Q4 24 | 21.6% | — | ||
| Q3 24 | 14.6% | — | ||
| Q2 24 | 11.7% | — |
现金转化率LBRTRPRX
| Q1 26 | — | — | ||
| Q4 25 | 14.28× | 3.86× | ||
| Q3 25 | 1.20× | 2.44× | ||
| Q2 25 | 2.40× | 12.06× | ||
| Q1 25 | 9.55× | 2.50× | ||
| Q4 24 | 3.42× | 3.57× | ||
| Q3 24 | 3.31× | 1.29× | ||
| Q2 24 | 2.29× | 6.45× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LBRT
暂无分部数据
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
